Vaxxas recognised in the Top 10 healthcare startups in Australia, 2021 AnnouncementCarolyn MillerNovember 10, 2021Vaxxas, Paul Kelly
QLD govt commits $20m to vaccine manufacturer InnovationAusCarolyn MillerJune 9, 2021Vaxxas, Paul Kelly
Preclinical studies from Vaxxas and Collaborators Reveal Potential of Vaxxas’ Novel High-Density Microarray Patch (HD-MAP) to Effectively Deliver SARS-CoV-2 Spike Vaccine Media ReleaseCarolyn MillerJune 3, 2021Vaxxas, Paul Kelly
Covid-19 vaccine could soon be needle-free The AustralianCarolyn MillerJune 3, 2021Vaxxas, Paul Kelly
No need for needle as COVID-19 vaccination patch shows promise Sydney Morning HeraldCarolyn MillerJune 3, 2021Vaxxas, Paul Kelly
Fresh funds for Qld needle-free vaccine tech start-up Vaxxas AFRCarolyn MillerOctober 6, 2020Vaxxas, Paul Kelly
Vaxxas Announces $22 Million Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response Media ReleaseCarolyn MillerOctober 6, 2020Paul Kelly, Vaxxas
Could Vaxxas’ tiny patches enable a better COVID-19 vaccine? Drug Delivery BusinessCarolyn MillerSeptember 8, 2020Vaxxas, Paul Kelly
The Advantages of the Microneedle Array Patch Harro HöfligerCarolyn MillerJune 20, 2020Vaxxas, Paul Kelly
Vaxxas announces that MSD exercises option to apply novel immune system activation platform for vaccine candidate Media ReleaseCarolyn MillerMay 29, 2020Vaxxas, Paul Kelly
Harro Höfliger and Vaxxas announce alliance to develop industrial‐scale aseptic processing line for vaccine products based on Vaxxas’ High Density Microarray Patch (HD‐MAP) Media ReleaseCarolyn MillerMay 28, 2020Vaxxas, Paul Kelly
High-density microarray patch could provide alternative to syringe vaccine delivery EPRCarolyn MillerMarch 25, 2020Vaxxas, Paul Kelly
Queensland researchers develop ‘vaccination patch’, backed by Bill Gates’ foundation Carolyn MillerMarch 19, 2020Vaxxas, Paul Kelly
Vaxxas Publication in PLoS Medicine Reveals Groundbreaking Clinical Research on Broad Potential of Novel High-Density Microarray Patch (HD-MAP) Media ReleaseCarolyn MillerMarch 17, 2020Vaxxas, Paul Kelly
Dreading the flu? More needles might help. The Wall Street JournalCarolyn MillerNovember 21, 2019Vaxxas, Paul Kelly
Biotechs warn Treasury of R&D bust if refunds are capped AFRCarolyn MillerApril 11, 2018Vaxxas, Michelle Deaker
Securing second-round funding can turbo-charge a young business Virgin Voyeur MagazineCarolyn MillerJuly 1, 2016OneVentures, Vaxxas, Michelle Deaker
Invetech and Vaxxas named recipients of the 2015 Good Design Award for Development of Nanopatch Jet Coating Instrument for Needle-Free Drug Delivery AwardsCarolyn MillerMay 29, 2015Vaxxas
